There are various reports on the performance of Philip Morris International in the market. Some key reports show that the company's stock faced a tumble due to sales missing estimates and lower-than-expected volumes of Zyn Pouches, leading to a 7% drop in shares and a 10.4% loss over four weeks. Despite these setbacks, other reports highlight the company's strong Q2 2025 results, including an increase in diluted EPS of 26.6% to $1.95 and a reiteration of its 'buy' rating by Needham & Company. Furthermore, the company has raised its full-year guidance. Institutional investors experienced a decrease in market cap, however, long-term gains remain beneficial. The Zacks Analyst blog also featured Philip Morris, indicating potential market interest. Interestingly, despite beating earnings expectations, the stock value fell. However, it's suggested a trend reversal may be emerging. Mature Analysts are recommending to buy the dip in Philip Morris stocks in order to profit from potential future growth. Morgan Stanley also recommends buying the dip in Philip Morris. Several investment firms have increased or decreased their positions in Philip Morris, highlighting fluctuating investor sentiment.
Philip Morris International PM News Analytics from Sat, 19 Apr 2025 07:00:00 GMT to Sat, 26 Jul 2025 20:37:32 GMT - Rating 0 - Innovation -4 - Information 6 - Rumor 2
